Pilot and Feasibility Program

$407,624P30FY2016DKNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Paper 39620114 Paper 39606431 Paper 39512934 Paper 39184030 Paper 39044860 Paper 38989865 Paper 38917015 Paper 38716736 Paper 38395488 Paper 38094040 Paper 38091175 Paper 37982872 Paper 37892610 Paper 37836428 Paper 37754663 Paper 37638450 Paper 37184230 Paper 37061021 Paper 37059333 Paper 36993600 Paper 36942655 Paper 36918278 Paper 36912136 Paper 36754687 Paper 36624530 Paper 36587142 Paper 36543124 Paper 36539012 Paper 36092274 Paper 35977804 Paper 35972459 Paper 35961998 Paper 35908591 Paper 35726867 Paper 35639426 Paper 35578348 Paper 35478469 Paper 35443740 Paper 35311453 Paper 35187590 Paper 35123579 Paper 35017061 Paper 34966854 Paper 34923573 Paper 34823065 Paper 34808192 Paper 34669431 Paper 34661621 Paper 34610499 Paper 34423791 Paper 34411987 Paper 34312617 Paper 34161290 Paper 34011630 Paper 33936069 Paper 33889159 Paper 33655764 Paper 33617890 Paper 33479269 Paper 33458705 Paper 33361597 Paper 33291682 Paper 33276146 Paper 33275313 Paper 33174295 Paper 33119154 Paper 33096810 Paper 33094876 Paper 32965550 Paper 32935533 Paper 32907378 Paper 32855515 Paper 32848033 Paper 32835842 Paper 32828873 Paper 32733043 Paper 32685690 Paper 32654086 Paper 32578346 Paper 32558017 Paper 32490319 Paper 32469130 Paper 32337854 Paper 32287314 Paper 32239671 Paper 32234448 Paper 32158918 Paper 32006214 Paper 31980446 Paper 31805439 Paper 31805014 Paper 31796586 Paper 31793629 Paper 31672265 Paper 31563215 Paper 31545922 Trial NCT02875353 Patent 7141546 Patent 6953786 Patent 5547844

Abstract

The overall goal of the CURE: DDRCC is to promote multidisciplinary research in the molecular and cell biology, physiology and pathophysiology of the digestive system, foster collaboration and facilitate training, education and recruitment of new investigators. The Pilot and Feasibility Studies (PFS) Program, which has been enhanced by partnering with the UCLA Center for Translational Science Institute (CTSI) and by direct institutional resources (see below), is a key component to achieve the goals of the Center. The leverage of PFS funds has provided an important mechanism for enhancing our PFS program via substantial institutional support. We anticipate that a similar enhancement of the PFS program will operate in the next funding period.

View original record on NIH RePORTER →